Global Health (BOM:543654) Beneish M-Score: -1.69 (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543654 Global Health Ltd BOM:543654
96 GF Score
Price ₹1,404.70
GF Value ₹1,562.98
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Global Health Beneish M-Score?

Global Health BOM:543654 -0.04% 96 Beneish M-Score is -1.69 as of Aug. 26, 2026. GuruFocus rates BOM:543654 with a GF Score™ of 96/100 and a GF Value™ of ₹1,562.98 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Global Health ranks worse than 85.06% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.69 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Global Health's Beneish M-Score or its related term are showing as below:

BOM:543654' s Beneish M-Score Range Over the Past 10 Years
Min: -2.33   Med: -1.81   Max: -1.62
Current: -1.69

During the past 7 years, the highest Beneish M-Score of Global Health was -1.62. The lowest was -2.33. And the median was -1.81.


Global Health Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Global Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Health Beneish M-Score Chart

Global Health Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial 0.00 -2.33 -1.78 -1.67 -1.67

Global Health Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.62 -1.84 -1.90 -1.67 -1.69

BOM:543654 vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Global Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Health Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Global Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Global Health's Beneish M-Score falls into.


BOM:543654
96GF Score
Global Health Ltd BOM:543654
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Global Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1281+0.528 * 0.9859+0.404 * 1.3074+0.892 * 1.2127+0.115 * 1.0045
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1548+4.679 * 0.094188-0.327 * 1.1397
=-1.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Total Receivables was ₹4,417 Mil.
Revenue was 13040.51 + 11590.47 + 11210.47 + 10992.22 = ₹46,834 Mil.
Gross Profit was 10096.8 + 9125.18 + 8653.88 + 8436.66 = ₹36,313 Mil.
Total Current Assets was ₹16,749 Mil.
Total Assets was ₹59,050 Mil.
Property, Plant and Equipment(Net PPE) was ₹39,109 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹2,464 Mil.
Selling, General, & Admin. Expense(SGA) was ₹7,220 Mil.
Total Current Liabilities was ₹6,271 Mil.
Long-Term Debt & Capital Lease Obligation was ₹11,271 Mil.
Net Income was 1587.27 + 1439.88 + 950.22 + 1584.41 = ₹5,562 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₹0 Mil.
Cash Flow from Operations was 0 + 0 + 0 + 0 = ₹0 Mil.
Total Receivables was ₹3,229 Mil.
Revenue was 10308.37 + 9312.52 + 9434.36 + 9565.55 = ₹38,621 Mil.
Gross Profit was 7917.8 + 7176.33 + 7142.32 + 7285.73 = ₹29,522 Mil.
Total Current Assets was ₹15,331 Mil.
Total Assets was ₹47,662 Mil.
Property, Plant and Equipment(Net PPE) was ₹30,361 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1,922 Mil.
Selling, General, & Admin. Expense(SGA) was ₹5,156 Mil.
Total Current Liabilities was ₹6,188 Mil.
Long-Term Debt & Capital Lease Obligation was ₹6,235 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4416.61 / 46833.67) / (3228.61 / 38620.8)
=0.094304 / 0.083598
=1.1281

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(29522.18 / 38620.8) / (36312.52 / 46833.67)
=0.764411 / 0.775351
=0.9859

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (16749.2 + 39109.19) / 59050.04) / (1 - (15331.23 + 30360.59) / 47662.3)
=0.05405 / 0.041343
=1.3074

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=46833.67 / 38620.8
=1.2127

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1922.08 / (1922.08 + 30360.59)) / (2464.09 / (2464.09 + 39109.19))
=0.059539 / 0.059271
=1.0045

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(7219.94 / 46833.67) / (5155.64 / 38620.8)
=0.154161 / 0.133494
=1.1548

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((11270.57 + 6271.31) / 59050.04) / ((6235.06 + 6188.17) / 47662.3)
=0.297068 / 0.260651
=1.1397

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(5561.78 - 0 - 0) / 59050.04
=0.094188

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Global Health has a M-score of -1.69 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.69 mean?
Global Health (BOM:543654) has a Beneish M-Score of -1.69 as of Aug. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Global Health and its competitors. According to the industry distribution chart, Global Health ranks #535 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 85.1%.
Is Global Health's Beneish M-Score too high?
Global Health's current Beneish M-Score is -1.69. Based on the distribution chart, Global Health ranks #535 out of 629 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Global Health has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Global Health's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Health ranks #535 out of 629 companies for Beneish M-Score. This places Global Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Global Health and its competitors. Global Health's current Beneish M-Score is -1.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (BOM:543654) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,562.98, compared to a current price of ₹1,404.70 — trading 10.1% below its estimated fair value. The current Beneish M-Score is -1.69. Global Health's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Global Health (BOM:543654), the current Beneish M-Score is -1.69 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Global Health (BOM:543654) Overvalued in 2026?

Based on GuruFocus' analysis, Global Health stock appears to be undervalued. The current stock price of ₹1,404.70 is trading 10.1% below its estimated GF Value™ of ₹1,562.98. GuruFocus considers Global Health to be Modestly Undervalued.

Key valuation signals for BOM:543654:

  • Beneish M-Score: -1.69
  • GF Value™: ₹1,562.98 vs. price of ₹1,404.70 (10.1% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the BOM:543654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Global Health Business Description

Other Exchanges MEDANTA:India
Address Medanta - The Medicity, Sector-38, Gurugram, HR, IND, 122001
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
96GF Score

Get the complete analysis for BOM:543654

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,404.70
Price
₹1,562.98
GF Value